We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$795M
AUM Growth
-$5M
(-0.63%)
Cap. Flow
-$111K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
25.95%
Holding
272
New
16
Increased
102
Reduced
113
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$559K |
| 2 |
AGN
Allergan Inc
AGN
|
+$512K |
| 3 |
DexCom
DXCM
|
+$454K |
| 4 |
Coca-Cola
KO
|
+$405K |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$370K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Interactive Brokers
IBKR
|
+$1.11M |
| 2 |
Reliance Steel & Aluminium
RS
|
+$1.04M |
| 3 |
ExxonMobil
XOM
|
+$866K |
| 4 |
Apple
AAPL
|
+$756K |
| 5 |
MZTI
The Marzetti Company
MZTI
|
+$655K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.84% |
| 2 | Healthcare | 16.35% |
| 3 | Consumer Staples | 12.39% |
| 4 | Technology | 11.78% |
| 5 | Financials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
iShares MSCI Japan ETF
EWJ
$22.7B
| $136K | 0.02% |
+2,661
| New | +$139K |
|
|
RESN
252
DELISTED
Resonant Inc.
RESN
| $45K | 0.01% |
+15,000
| New | +$60.3K |
|
253
InfuSystem Holdings
INFU
$240M
| $32K | ﹤0.01% |
10,000
| – | – |
|
|
LQMT
254
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
| $27K | ﹤0.01% |
213,000
| – | – |
|
|
ELON
255
DELISTED
Echelon Corp
ELON
| $8K | ﹤0.01% |
1,000
| – | – |
|
256
Acacia Research
ACTG
$436M
| – | – |
-16,190
| Closed | -$173K |
|
257
Ameresco
AMRC
$1.17B
| – | – |
-15,200
| Closed | -$112K |
|
|
258
Interactive Brokers
IBKR
$43.4B
| – | – |
-130,800
| Closed | -$1.11M |
|
259
Teva Pharmaceuticals
TEVA
$42.5B
| – | – |
-4,104
| Closed | -$256K |
|
260
Tesla
TSLA
$1.38T
| – | – |
-17,550
| Closed | -$221K |
|
|
AGN
261
DELISTED
Allergan plc
AGN
| – | – |
-1,631
| Closed | -$485K |
|
|
CRC
262
DELISTED
California Resources Corporation
CRC
| – | – |
-1,233
| Closed | -$94K |
|
|
ALU
263
DELISTED
Alcatel-Lucent
ALU
| – | – |
-23,410
| Closed | -$87K |
|
Similar funds
AC
CCM
MIAN
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q2 2015 Portfolio in Review
As of Q2 2015, Dowling & Yahnke held 272 positions worth $795M, down 0.63% from $800M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Dowling & Yahnke's Q2 2015 filing shows 16 new, 102 increased, 113 reduced and 8 closed positions. Its largest new stake was Evolent Health: 30,000 shares worth $585K. The largest sale was Interactive Brokers, an estimated $1.11M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.
- Dowling & Yahnke's largest Q2 2015 buy was Evolent Health: 30,000 shares worth $585K.
- Dowling & Yahnke added most to DexCom in Q2 2015, an estimated $454K increase.
- Dowling & Yahnke's biggest Q2 2015 reduction was Reliance Steel & Aluminium, cutting an estimated $1.04M.
- Dowling & Yahnke fully exited Interactive Brokers in Q2 2015, selling an estimated $1.11M.
- Dowling & Yahnke's ten largest holdings make up 26% of its $795M portfolio in Q2 2015.
- Dowling & Yahnke opened 16 new positions and closed 8 in Q2 2015.
- Dowling & Yahnke's portfolio value fell 0.63% quarter-over-quarter to $795M.
Based on Dowling & Yahnke's 13F filing for Q2 2015, filed 22 Jul 2015.